These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 8217124)

  • 21. Treatment-emergent tardive dyskinesia with quetiapine in mood disorders.
    Sharma V
    J Clin Psychopharmacol; 2003 Aug; 23(4):415-7. PubMed ID: 12920421
    [No Abstract]   [Full Text] [Related]  

  • 22. Dyskinetic movements, cognitive impairment, and negative symptoms in elderly neuropsychiatric patients.
    Karson CN; Bracha HS; Powell A; Adams L
    Am J Psychiatry; 1990 Dec; 147(12):1646-9. PubMed ID: 2244644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Treatment of tardive dyskinesia with levetiracetam in a transplant patient.
    Zivković SA; Costa G; Bond G; Abu-Elmagd KM
    Acta Neurol Scand; 2008 May; 117(5):351-3. PubMed ID: 17995990
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Tardive dyskinesia: pergolid, a possible therapeutic option].
    Diehl A; Braus DF; Büchel C; Krumm B; Medori R; Gattaz WF
    Psychiatr Prax; 2003 Sep; 30(6):333-7. PubMed ID: 12970819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antipsychotic-induced tardive movement disorders: a series of twelve cases.
    Kasantikul D; Kanchanatawan B
    J Med Assoc Thai; 2007 Jan; 90(1):188-94. PubMed ID: 17621754
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Utility of quetiapine in tardive dyskinesia].
    Navarro Pacheco BV; Montejo González AL; Martín Carrasco M
    Actas Esp Psiquiatr; 2003; 31(6):347-52. PubMed ID: 14639511
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Characterizing behavioral and cognitive dysexecutive changes in progressive supranuclear palsy.
    Millar D; Griffiths P; Zermansky AJ; Burn DJ
    Mov Disord; 2006 Feb; 21(2):199-207. PubMed ID: 16200534
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Tardive dyskinesia: a review].
    Crespo Facorro B; Payá González B; Ruiz Fernández V; Carbonell Masia C
    Actas Luso Esp Neurol Psiquiatr Cienc Afines; 1997; 25(2):118-27. PubMed ID: 9245189
    [TBL] [Abstract][Full Text] [Related]  

  • 29. New models of frontal-subcortical skeletomotor circuit pathology in tardive dyskinesia.
    Marchand WR; Dilda V
    Neuroscientist; 2006 Jun; 12(3):186-98. PubMed ID: 16684965
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case series on the hypothesized connection between dementia and bipolar spectrum disorders: bipolar type VI?
    Ng B; Camacho A; Lara DR; Brunstein MG; Pinto OC; Akiskal HS
    J Affect Disord; 2008 Apr; 107(1-3):307-15. PubMed ID: 17889374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Differential striatal levels of TNF-alpha, NFkappaB p65 subunit and dopamine with chronic typical and atypical neuroleptic treatment: role in orofacial dyskinesia.
    Bishnoi M; Chopra K; Kulkarni SK
    Prog Neuropsychopharmacol Biol Psychiatry; 2008 Aug; 32(6):1473-8. PubMed ID: 18554768
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tardive dyskinesia and impaired glucose tolerance.
    Chong SA; Mythily ; Lum A; Huak CY; Kane J
    Hum Psychopharmacol; 2002 Aug; 17(6):305-7. PubMed ID: 12404676
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tardive dysmentia : further comments.
    Jones BD
    Schizophr Bull; 1985; 11(2):187-9. PubMed ID: 2861654
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Protective effect of Curcumin, the active principle of turmeric (Curcuma longa) in haloperidol-induced orofacial dyskinesia and associated behavioural, biochemical and neurochemical changes in rat brain.
    Bishnoi M; Chopra K; Kulkarni SK
    Pharmacol Biochem Behav; 2008 Feb; 88(4):511-22. PubMed ID: 18022680
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Withdrawal-emergent dyskinesia in patients with schizophrenia during antipsychotic discontinuation.
    Schultz SK; Miller DD; Arndt S; Ziebell S; Gupta S; Andreasen NC
    Biol Psychiatry; 1995 Dec; 38(11):713-9. PubMed ID: 8580223
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Hyperventilation as a variant of tardive dyskinesia.
    Greenberg DB; Murray GB
    J Clin Psychiatry; 1981 Oct; 42(10):401-3. PubMed ID: 6793559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical effectiveness of the Kampo medicine kamishoyosan for adjunctive treatment of tardive dyskinesia in patients with schizophrenia: a 16-week open trial.
    Lee JG; Shin BS; Lee YC; Park SW; Kim YH
    Psychiatry Clin Neurosci; 2007 Oct; 61(5):509-14. PubMed ID: 17875029
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Tardive dyskinesia, the involuntary movement disorder that no one really understands.
    Jewell JA; Chemij M
    Can Nurse; 1983 Jun; 79(6):20-4. PubMed ID: 6552925
    [No Abstract]   [Full Text] [Related]  

  • 39. New nomenclature for drug-induced movement disorders including tardive dyskinesia.
    Chouinard G
    J Clin Psychiatry; 2004; 65 Suppl 9():9-15. PubMed ID: 15189106
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hyperkinetic movement disorders misdiagnosed as tics in Gilles de la Tourette syndrome.
    Kompoliti K; Goetz CG
    Mov Disord; 1998 May; 13(3):477-80. PubMed ID: 9613740
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.